Plant Comparison
Lingzhi vs Panax Ginseng
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Lingzhi and Panax Ginseng: they share 8 indicated uses (arthritis / joint pain, blood sugar / diabetes support, cardiovascular / heart health, …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Lingzhi | Panax Ginseng | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Blood sugar / diabetes support | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Cardiovascular / heart health | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Cold & flu | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Immune support | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Metabolic support | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Skin irritation | 1/10 | 5/10 | Stronger for Panax Ginseng |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Principal immunomodulatory constituents, the main focus of anticancer-adjunct and immune research.
Bitter triterpenes associated with anti-inflammatory, hepatoprotective and adaptogenic activity.
The principal bioactive triterpene saponins of the root, considered responsible for most of ginseng's adaptogenic, neuroprotective and immunomodulatory activity; the ratio of protopanaxadiol- to protopanaxatriol-type ginsenosides differs between fresh, white and red ginseng.
Contribute to the immunomodulatory activity of the root.
Minor constituents contributing to the aroma and antioxidant activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from antiviral action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from ergogenic action
Safety, Cautions & Contraindications
Generally well tolerated at standard doses. May cause mild digestive upset, dry mouth, or dizziness in some individuals. May enhance the effects of anticoagulant and antihypertensive medications. Avoid during pregnancy and breastfeeding. Extended use beyond 6 months is not well studied in humans.
Duke (2002) rates reishi (Ganoderma lucidum) as + and notes immunostimulant, hepatoprotective, antioxidant, antitumor, and hypoglycemic activities at the experimental level (score 1). It is a key adaptogen in traditional Chinese medicine, valued for its polysaccharide (beta-glucan) content. Duke notes antiviral (score 1) and anti-aggregant activities. No strong clinical trials existed at time of publication, but lentinan and polysaccharide fractions from related species show immunomodulatory potential. Duke suggests caution in bleeding disorders due to anti-aggregant activity (Duke, 2002).
Generally well tolerated in short-term use (up to 3 months). May cause insomnia, headache, or gastrointestinal upset at high doses. Avoid during pregnancy and breastfeeding. May interact with warfarin, MAOIs, and diabetic medications. Not recommended for continuous use without breaks.
Duke (2002) rates Korean/Oriental ginseng (Panax ginseng) as highly active with clinical support for adaptogenic, immunostimulant, and performance-enhancing effects. Commission E approves standardized ginseng root extract (4–7% ginsenosides) as a tonic for fatigue and during convalescence. Dose: 200–600 mg standardized extract daily. Duke cautions about 'Ginseng Abuse Syndrome' (GAS) with overdose — symptoms include hypertension, insomnia, edema, and nervousness. Drug interactions are notable: ginseng potentiates MAOIs and may interact with warfarin, digoxin, and stimulants. Cycle use (2–3 weeks on, 2 weeks off) is recommended (Duke, 2002).
External Ids
Botanical Description
Bracket (shelf) fungus (not a true plant) that grows on the trunks and stumps of deciduous trees. It develops a hard, kidney- or fan-shaped cap with a glossy, varnished, red-brown to mahogany crust and concentric growth rings, often on a lateral woody stalk; the pale underside is covered in fine pores that release rusty-brown spores. The mycelium spreads through the wood substrate before fruiting.[1]
Slow-growing perennial herb (Araliaceae), 30-60 cm tall, harvested at 4 years of age or older. A single erect stem bears a whorl of palmately compound leaves, each with 3-5 toothed leaflets, at its top. Small greenish-white flowers are borne in a single terminal umbel, followed by small red berries. The fleshy, often forked or human-shaped taproot - the origin of the name 'ginseng' ('renshen', man-root) - is the medicinal part.[3]
Habitat
Grows as a wood-decay fungus on the stumps and trunks of deciduous trees (notably maple and other hardwoods) in East Asian forests; also widely cultivated commercially on hardwood logs or sawdust substrate.
Native to the cool-temperate deciduous mountain forests of Manchuria, Korea and the Russian Far East. Historically wild-harvested, it is now predominantly cultivated, mainly in Korea and China, under artificial shade for several years before harvest.[1]
Harvesting
Wild fruiting bodies are collected once mature; cultivated material is harvested from logs or substrate at maturity, then dried and processed into slices, powder or extract.
The root is harvested after at least 4-6 years of growth, once its ginsenoside content is fully developed. Roots are either air-dried as 'white ginseng' or steamed and then dried as 'red ginseng', a processing step that alters the ginsenoside profile.[3]
Traditional Uses
Reishi/lingzhi, the 'mushroom of immortality', is one of the most revered tonic fungi in traditional Chinese medicine, used for centuries to support vitality, calm the spirit, strengthen immunity and promote longevity; this traditional tonic reputation is now studied for immunomodulatory, anticancer-adjunct and metabolic effects.[1, 4]
Ginseng is one of the most celebrated tonic herbs of East Asian traditional medicine, used for millennia as a general adaptogen to restore vitality, support recovery from illness and improve stamina and cognitive performance. Modern clinical research supports adaptogenic, immunomodulatory, antioxidant, neuroprotective and mild antidiabetic effects consistent with this traditional use.[1, 7]
Preparations
Commission E-recognised standardised extract (4-7% ginsenosides), the most clinically studied preparation.
Traditional processed form (steamed then dried), which alters and concentrates the ginsenoside profile compared with white (unprocessed) ginseng.
References
Drug Class Interactions
Lookalikes Review
Dangerous Lookalikes
Not documented
Dosage
Pairings
Not documented
Ginseng and feverfew both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 20]
Ginseng and ginger both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 21]
References & Sources
- Li, W., Zhou, Q., Lv, B., Li, N. et al (2024) 'Ganoderma lucidum Polysaccharide Supplementation Significantly Activates T-Cell-Mediated Antitumor Immunity and Enhances Anti-PD-1 Immunotherapy Efficacy in Colorectal Cancer', Journal of Agricultural and Food Chemistry, 72(21), pp. 12072-12082. doi:10.1021/acs.jafc.3c08385 Preclinical
https://doi.org/10.1021/acs.jafc.3c08385 - Cai, Q., Li, Y. and Pei, G (2017) 'Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response', Journal of Neuroinflammation, 14(1), pp. 63. doi:10.1186/s12974-017-0839-0 Preclinical
https://doi.org/10.1186/s12974-017-0839-0 - Zheng, G., Zhao, Y., Li, Z., Hua, Y. et al (2023) 'Ganoderma lucidum spore powder and derived triterpenes attenuate atherosclerosis and aortic calcification by stimulating ABCA1/G1-mediated macrophage cholesterol efflux and inactivating RUNX2-mediated VSMC osteogenesis', Theranostics, 13(4), pp. 1325-1341. doi:10.7150/thno.80250 Preclinical
https://doi.org/10.7150/thno.80250 - Sohretoglu, D. and Huang, S (2018) 'Ganoderma lucidum Polysaccharides as An Anti-cancer Agent', Anti-Cancer Agents in Medicinal Chemistry, 18(5), pp. 667-674. doi:10.2174/1871520617666171113121246 Meta-analysis / review
https://doi.org/10.2174/1871520617666171113121246 - Seweryn, E., Ziala, A. and Gamian, A (2021) 'Health-Promoting of Polysaccharides Extracted from Ganoderma lucidum', Nutrients, 13(8), pp. 2725. doi:10.3390/nu13082725 Meta-analysis / review
https://doi.org/10.3390/nu13082725 - Liu, X., Yang, L., Li, G., Jiang, Y., Zhang, G. and Ling, J (2022) 'A novel promising neuroprotective agent: Ganoderma lucidum polysaccharide', International Journal of Biological Macromolecules, 229, pp. 168-180. doi:10.1016/j.ijbiomac.2022.12.276 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2022.12.276 - Zhu, M., Chang, Q., Wong, L.K., Chong, F.S. and Li, R.C (1999) 'Triterpene antioxidants from Ganoderma lucidum', Phytotherapy Research, 13(6), pp. 529-531. doi:10.1002/(sici)1099-1573(199909)13:6<529::aid-ptr481>3.0.co;2-x Preclinical
https://doi.org/10.1002/(sici)1099-1573(199909)13:6<529::aid-ptr481>3.0.co;2-x - Zeng, P., Chen, Y., Zhang, L. and Xing, M (2019) 'Ganoderma lucidum polysaccharide used for treating physical frailty in China', Progress in Molecular Biology and Translational Science, 163, pp. 179-219. doi:10.1016/bs.pmbts.2019.02.009 Meta-analysis / review
https://doi.org/10.1016/bs.pmbts.2019.02.009 - Wu, P., Zhang, C., Yin, Y., Zhang, X., Li, Q., Yuan, L., Sun, Y., Zhou, S., Ying, S. and Wu, J (2024) 'Bioactivities and industrial standardization status of Ganoderma lucidum: A comprehensive review', Heliyon, 10(19), pp. e36987. doi:10.1016/j.heliyon.2024.e36987 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e36987 - Xu, Z., Chen, X., Zhong, Z., Chen, L. and Wang, Y (2011) 'Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities', The American Journal of Chinese Medicine, 39(1), pp. 15-27. doi:10.1142/S0192415X11008610 Meta-analysis / review
https://doi.org/10.1142/S0192415X11008610 - Geng, X., Zhong, D., Su, L., Lin, Z. and Yang, B (2019) 'Preventive and therapeutic effect of Ganoderma lucidum on kidney injuries and diseases', Advances in Pharmacology, 87, pp. 257-276. doi:10.1016/bs.apha.2019.10.003 Meta-analysis / review
https://doi.org/10.1016/bs.apha.2019.10.003 - Sliva, D (2004) 'Cellular and physiological effects of Ganoderma lucidum (Reishi)', Mini Reviews in Medicinal Chemistry, 4(8), pp. 873-879. doi:10.2174/1389557043403323 Meta-analysis / review
https://doi.org/10.2174/1389557043403323 - Boh, B., Berovic, M., Zhang, J. and Zhi-Bin, L (2007) 'Ganoderma lucidum and its pharmaceutically active compounds', Biotechnology Annual Review, 13, pp. 265-301. doi:10.1016/S1387-2656(07)13010-6 Meta-analysis / review
https://doi.org/10.1016/S1387-2656(07)13010-6 - Bao, X. et al (2001) 'Structural requirements for the immunological activities of polysaccharides from Ganoderma lucidum', 41(9), pp. 2603--2611. Traditional / reference
https://scholar.google.com/scholar?q=Structural%20requirements%20for%20the%20immunological%20activities%20of%20polysaccharides%20from%20Ganoderma%20lucidum - Jin, X. et al (2012) 'Ganoderma lucidum (Reishi mushroom) for cancer treatment'. Traditional / reference
https://scholar.google.com/scholar?q=Ganoderma%20lucidum%20%28Reishi%20mushroom%29%20for%20cancer%20treatment - Wachtel-Galor, S., Yuen, J., Buswell, J.A. and Benzie, I.F.F (2011) 'Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom'. Traditional / reference
https://scholar.google.com/scholar?q=Ganoderma%20lucidum%20%28Lingzhi%20or%20Reishi%29%3A%20A%20Medicinal%20Mushroom - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Ahn, J.Y. and Seok, S.J. and Song, J.E. and Choi, J.H. and Han, S.H. and Choi, J.Y. and Kim, C.O. and Song, Y.G. and Kim, J.M (2013) 'Two cases of mushroom poisoning by Podostroma cornu-damae', Yonsei Medical Journal, 54(1), pp. 265-8. doi:10.3349/ymj.2013.54.1.265 Clinical study
https://doi.org/10.3349/ymj.2013.54.1.265 - Choe, S. and In, S. and Jeon, Y. and Choi, H. and Kim, S (2018) 'Identification of trichothecene-type mycotoxins in toxic mushroom Podostroma cornu-damae and biological specimens from a fatal case by LC-QTOF/MS', Forensic Science International, 291, pp. 234-244. doi:10.1016/j.forsciint.2018.08.043 Clinical study
https://doi.org/10.1016/j.forsciint.2018.08.043
- Mancuso, C. and Santangelo, R (2017) 'Panax ginseng and Panax quinquefolius: From pharmacology to toxicology', Food and Chemical Toxicology, 107(Pt A), pp. 362-372. doi:10.1016/j.fct.2017.07.019 Meta-analysis / review
https://doi.org/10.1016/j.fct.2017.07.019 - Zhou, Z., Li, M., Zhang, Z., Song, Z. and others (2024) 'Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases', Journal of Ethnopharmacology, 334, pp. 118506. doi:10.1016/j.jep.2024.118506 Meta-analysis / review
https://doi.org/10.1016/j.jep.2024.118506 - Liu, H., Lu, X., Hu, Y. and Fan, X (2020) 'Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy', Pharmacological Research, 161, pp. 105263. doi:10.1016/j.phrs.2020.105263 Meta-analysis / review
https://doi.org/10.1016/j.phrs.2020.105263 - Fan, S., Zhang, Z., Su, H., Xu, P. and others (2020) 'Panax ginseng clinical trials: Current status and future perspectives', Biomedicine & Pharmacotherapy, 132, pp. 110832. doi:10.1016/j.biopha.2020.110832 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2020.110832 - Ni, X.C., Wang, H.F., Cai, Y.Y., Yang, D. and others (2022) 'Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke', Redox Biology, 54, pp. 102363. doi:10.1016/j.redox.2022.102363 Preclinical
https://doi.org/10.1016/j.redox.2022.102363 - Arring, N.M., Millstine, D., Marks, L.A. and Nail, L.M (2018) 'Ginseng as a Treatment for Fatigue: A Systematic Review', Journal of Alternative and Complementary Medicine, 24(7), pp. 624-633. doi:10.1089/acm.2017.0361 Meta-analysis / review
https://doi.org/10.1089/acm.2017.0361 - Zhou, G., Wang, C.Z., Mohammadi, S., Sawadogo, W.R. and others (2023) 'Pharmacological Effects of Ginseng: Multiple Constituents and Multiple Actions on Humans', The American Journal of Chinese Medicine, 51(5), pp. 1085-1104. doi:10.1142/S0192415X23500507 Meta-analysis / review
https://doi.org/10.1142/S0192415X23500507 - Ramanathan, M.R. and Penzak, S.R (2017) 'Pharmacokinetic Drug Interactions with Panax ginseng', European Journal of Drug Metabolism and Pharmacokinetics, 42(4), pp. 545-557. doi:10.1007/s13318-016-0387-5 Meta-analysis / review
https://doi.org/10.1007/s13318-016-0387-5 - Li, J., Huang, Q., Chen, J., Qi, H. and others (2021) 'Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences', Frontiers in Pharmacology, 12, pp. 688490. doi:10.3389/fphar.2021.688490 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.688490 - Geng, J., Dong, J., Ni, H., Lee, M.S. and others (2010) 'Ginseng for cognition', Cochrane Database of Systematic Reviews, (12), pp. CD007769. doi:10.1002/14651858.CD007769.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD007769.pub2 - Attele, A.S., Wu, J.A. and Yuan, C.S (1999) 'Ginseng pharmacology: multiple constituents and multiple actions', 58(11), pp. 1685--1693. doi:10.1016/s0006-2952(99)00212-9 Traditional / reference
https://doi.org/10.1016/s0006-2952(99)00212-9 - Kiefer, D. and Pantuso, T (2003) 'Panax ginseng', 68(8), pp. 1539--1542. Traditional / reference
https://scholar.google.com/scholar?q=Panax%20ginseng - Park, H.J., Kim, D.H. and Park, S.J (2014) 'Ginseng in traditional herbal prescriptions', 38(1), pp. 1--7. doi:10.5142/jgr.2012.36.3.225 Randomized trial
https://doi.org/10.5142/jgr.2012.36.3.225 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Yuan, C.S., Wei, G., Dey, L., Karrison, T., Nahlik, L., Maleckar, S., Kasza, K., Ang-Lee, M. and Moss, J (2004) 'American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial', Annals of Internal Medicine, 141(1), pp. 23-27. doi:10.7326/0003-4819-141-1-200407060-00011 Randomized trial
https://doi.org/10.7326/0003-4819-141-1-200407060-00011 - Sotaniemi, E.A., Haapakoski, E. and Rautio, A (1995) 'Ginseng therapy in non-insulin-dependent diabetic patients', Diabetes Care, 18(10), pp. 1373-1375. doi:10.2337/diacare.18.10.1373 Randomized trial
https://doi.org/10.2337/diacare.18.10.1373 - Vuksan, V., Sievenpiper, J.L., Koo, V.Y., Francis, T., Beljan-Zdravkovic, U., Xu, Z. and Vidgen, E (2000) 'American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus', Archives of Internal Medicine, 160(7), pp. 1009-1013. doi:10.1001/archinte.160.7.1009 Randomized trial
https://doi.org/10.1001/archinte.160.7.1009 - Ang-Lee, M.K., Moss, J. and Yuan, C.S (2001) 'Herbal medicines and perioperative care', JAMA, 286(2), pp. 208-216. doi:10.1001/jama.286.2.208 Meta-analysis / review
https://doi.org/10.1001/jama.286.2.208 - Groenewegen, W.A. and Heptinstall, S (1990) 'A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro', Journal of Pharmacy and Pharmacology, 42(8), pp. 553-557. doi:10.1111/j.2042-7158.1990.tb07057.x Preclinical
https://doi.org/10.1111/j.2042-7158.1990.tb07057.x - Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O. and McLachlan, A.J (2005) 'Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 59(4), pp. 425-432. doi:10.1111/j.1365-2125.2005.02322.x Randomized trial
https://doi.org/10.1111/j.1365-2125.2005.02322.x
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.